U.S. Markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
154.20+1.35 (+0.88%)
At close: 3:59PM EDT

154.15 -0.05 (-0.03%)
After hours: 4:04PM EDT

People also watch

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States

IndustryMedical Laboratories & Research
Full Time Employees52,000

Key Executives

Mr. David P. King J.D.Chairman, CEO & Pres3.07M11.36M61
Mr. Glenn A. EisenbergChief Financial Officer and Exec. VP1.34MN/A56
Mr. Lance V. BerberianChief Information Officer and Sr. VP612.04kN/A54
Mr. F. Samuel Eberts IIIChief Legal Officer, Chief Compliance Officer, Sr. VP and Sec.803.3kN/A57
Mrs. Lisa J. UthgenanntChief HR Officer and Sr. VP770.85kN/A56
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. It also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, the company provides drug development solutions, as well as laboratory testing services. Further, it provides its testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Duke University, Johns Hopkins University, Boston University, Columbia University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Corporate Governance

Laboratory Corporation of America Holdings’s ISS Governance QualityScore as of September 1, 2017 is 1. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.